NHS England (NHSE) has announced that the Pharmacy Contraception Service will launch from 24th April 2023. This start date for the service has not been agreed with PSNC and is in direct contradiction of our warning to Ministers that no new or expanded services can be rolled out in 2023/24 unless extra funding is put [...]
The post NHSE announces contraception service launch appeared first on PSNC Website.
Department of Health and Social Care (DHSC) has issued a medicine supply notification for Estradiol (Estradot®) 75micrograms/24hours transdermal patches. MSN/2023/047 Tier 2 – medium impact Date of issue 13th April 2023 Estradiol (Estradot®) 75micrograms/24hours transdermal patches are out of stock until early May 2023. An alternative brand of estradiol patches, Evorel®, available as 75micrograms/24hours can [...]
The post Medicine Supply Notification: Estradiol (Estradot® ) 75micrograms/24hours transdermal patches appeared first on PSNC Website.
In response to a significant ongoing disruption to the supply of Estradot® 75micrograms/24hours patches, a Serious Shortage Protocol (SSP) has been issued by the Department of Health and Social Care (DHSC). Effective today, 13 April 2023, SSP055 provides that for every Estradot® 75micrograms/24hours patch originally prescribed, one Evorel® 75 patch must be supplied. SSP055, authorised by the Secretary [...]
The post SSP issued for Estradot® 75mcg patches appeared first on PSNC Website.
PSNC’s 2023 Pharmacy Pressures Survey has confirmed the worsening situation for community pharmacies as rising costs and significantly increased workload is putting businesses at greater risk of collapse. The survey of over 6,200 pharmacy premises and 2,000 pharmacy team members shows a very worrying picture of the impact of the current pressures on pharmacies and [...]
The post Pressures Survey confirms rising costs, patient demand and medicine supply issues continue to grip community pharmacy appeared first on PSNC Website.
Department of Health and Social Care (DHSC) has issued a medicine supply notification for Alfuzosin 10mg modified release tablets. MSN/2023/045 Tier 2 – medium impact Date of issue 12th April 2023 There is limited supply of alfuzosin 10mg modified release tablets until w/c 15th May 2023. Alternative alpha-adrenoceptor blockers licensed for the symptomatic treatment of [...]
The post Medicine Supply Notification: Alfuzosin 10mg modified release tablets appeared first on PSNC Website.
Recent Comments